Xenetic Biosciences, Inc. - Common Stock (XBIO)

About Xenetic Biosciences, Inc. - Common Stock (XBIO)

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences, Inc. - Common Stock News